Insurtech funding in 2018 close to all time record

A cash injection syringe

Insurtech start-ups deals reached $2.6bn (£2.3bn) in 2018, with a highest ever volume of 204 deals, research found.

The figures from Hampleton Partners, show the transaction value for 2018 so far is already close to the 2015 peak of $2.7bn, which had 124 deals.

In 2017, there were 202 insurtech deals worth $2.2bn, and 2016 saw 174 deals for a value of $1.7bn.

Miro Parizek, founder of Hampleton Partners said: “There’s an army of insurtech startups which are challenging legacy players. The market has adopted a survival of the fittest environment.

“Since organic growth and investing in R&D is a long-term game, M&A has been the natural solution to the incumbents’ problem of accelerating technological transformation and evolving their traditional business models for the 21st century.

“Next-generation insurance is having to evolve quickly with new business models and a greater focus on technology innovation. 

“Insurtechs  have become a natural threat to incumbents, but also potential valuable partners in this changing landscape. It’s a sector that’s growing rapidly and stands to capture a meaningful share of the value pools within a few years. How quickly incumbents adapt to these inexorable market changes will determine the size of their share in the next generation of the insurance industry.”

  • LinkedIn  
  • Save this article
  • Print this page  

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: